Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study. [electronic resource]
Producer: 20030425Description: 500-8 p. digitalISSN:- 1524-9557
- Adjuvants, Immunologic -- therapeutic use
- Adult
- Antibodies, Neoplasm -- biosynthesis
- Antigens, Neoplasm -- immunology
- Cancer Vaccines -- therapeutic use
- Carcinoma, Renal Cell -- drug therapy
- Cell Differentiation
- Combined Modality Therapy
- Dendritic Cells -- immunology
- Feasibility Studies
- Follow-Up Studies
- Granulocyte-Macrophage Colony-Stimulating Factor -- pharmacology
- Humans
- Hypersensitivity, Delayed -- immunology
- Immunization Schedule
- Immunologic Memory
- Immunophenotyping
- Interferon-gamma -- metabolism
- Interleukin-2 -- therapeutic use
- Interleukin-4 -- pharmacology
- Kidney Neoplasms -- drug therapy
- Lymphocyte Activation
- Lymphocyte Subsets -- immunology
- Monocytes -- cytology
- Nephrectomy
- Recombinant Proteins -- pharmacology
- Treatment Outcome
- Vaccination
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.